Clinical Trial Update: Gemcitabine Plus Cisplatin Single Dose Versus Split Dose in the Treatment of Patients With Locally Advanced or Metastatic Breast Cancer After Failure of Anthracyclines and/or Taxanes [Phase 2]

View source ↗

Summary

A Phase 2 trial comparing single-dose versus split-dose gemcitabine plus cisplatin in locally advanced or metastatic breast cancer after prior anthracycline/tax…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Gemzar (gemcitabine)
• Platinol (cisplatin)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Metastatic Breast Cancer | Phase 2 | Status: COMPLETED